stockportfolio.pro
Stocks / NUVL vs UHS
NUVL vs UHS: Which Stock Is the Better Buy?
Nuvalent, Inc. and Universal Health Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
NUVL is the larger company ($9.8B vs $9.6B). On the fundamentals, UHS has the stronger return on equity (20.5% vs -34.1%). On the filings, UHS carries fewer potential red flags (0 vs 1). Full numbers below — the stronger figure on each row is in green.
AI verdict — NUVL vs UHS, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Nuvalent, Inc. (NUVL) | Universal Health Services, Inc. (UHS) | |
|---|---|---|
| Market cap | $9.8B | $9.6B |
| Revenue (latest FY) | $0 | $17.36B |
| Net income (latest FY) | $-425.38M | $1.49B |
| Revenue growth (5y CAGR) | — | 8.5% |
| Net margin | — | 8.6% |
| Return on equity | -34.1% | 20.5% |
| P/E ratio | — | 6.6 |
| Dividend yield | — | 0.5% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | — | Yes |
Compare with another company:
See the full NUVL vs UHS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open NUVL's full financials → Open UHS's full financials →More comparisons
Frequently asked questions
Which is bigger, NUVL or UHS?
Nuvalent, Inc. is larger by market capitalization — $9.8B versus $9.6B.
Which grows faster, NUVL or UHS?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.